Evidence map›Paper›PMID 38887488›Full record

ArticleOpen forum infectious diseases2024

Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4

Adam S Komorowski, Patryk Aftanas, Vanessa Porter, Kevin Katz, Robert A Kozak, Xena X Li

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Nucleic Acid Amplification Tests forPathogens (Basel, Switzerland) · 2026
    Pooled it
  2. RefractoryASM case reports · 2026
    Article
  3. Evaluation of a high-throughputMicrobiology spectrum · 2025
    Article
  4. Diagnostic Approaches forMicroorganisms · 2025
    Review
  5. Article
  6. Review
  7. Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  8. Consensus paper onTurkish journal of medical sciences · 2025
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam S KomorowskiMedical Microbiology, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0003-2101-7701
Patryk AftanasShared Hospital Laboratory, Toronto, Ontario, Canada.
Vanessa PorterShared Hospital Laboratory, Toronto, Ontario, Canada.
Kevin KatzShared Hospital Laboratory, Toronto, Ontario, Canada.
Robert A KozakShared Hospital Laboratory, Toronto, Ontario, Canada.
Xena X LiShared Hospital Laboratory, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-1510-6310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this verification study, we compare and contrast the performance characteristics of chromogenic agar culture, direct polymerase chain reaction (PCR), and broth enrichment followed by culture or PCR for the detection of

Indexed as

antifungal drug resistanceCandida auriscarrier statecost-effectiveness analysisdiagnostic screening programs

Identifiers

PMID38887488
PMCPMC11181175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.